市场监管总局批准发布的《社会化陪同就医服务 基本要求》（GB/T 47801—2026）将于2026年11月1日正式实施 1。该标准旨在规范兴起的陪诊行业，解决服务质量参差不齐的问题，对陪诊服务的提供者资格、服务内容范围及违规边界进行了明确界定 1。
根据新国标，陪诊服务的提供方被定义为“机构”，其人员称为“陪诊师” 1。服务对象包括因行动、认知、地域差异等导致就医不便者或追求更好体验的个人 1。在行为规范方面，标准明确了禁止行为，规定不得判读检查结果、参与医疗操作、提供医疗建议、调整用药方案、代替签署法律文书等 1。
针对如何保障服务合规性，北京中医药大学法律系教授邓勇建议建立“准入备案、行为管控、公示监督”机制及多部门联合监管 1。
China’s State Administration for Market Regulation has approved and released a new national standard titled "Basic Requirements for Socialized Accompanied Medical Services," designated as GB/T 47801—2026. 1 The regulation is scheduled to officially come into force on November 1, 2026, aiming to regulate the emerging industry of accompanied medical visits and address issues regarding inconsistent service quality. 1
The new standard clearly defines service providers as "institutions" and their staff as "accompanying medical service specialists." 1 These services are intended for individuals facing difficulties in seeking medical care due to mobility constraints, cognitive impairments, or geographical disparities, as well as those seeking an enhanced patient experience. 1 To ensure compliance, the standard strictly prohibits accompanying specialists from interpreting test results, participating in medical procedures, offering medical advice, adjusting medication plans, or signing legal documents on behalf of patients. 1 Deng Yong, a professor at the Department of Law at Beijing University of Chinese Medicine, recommends establishing mechanisms for entry registration, behavioral control, and public supervision, alongside multi-departmental joint enforcement to safeguard regulatory adherence. 1
评论
还没有评论，欢迎留下第一条。